Trending
Revolutionary Shows Promise 4
Revolutionary Shows Promise 3
Revolutionary Shows Promise 1
Revolutionary aids Treatment Shows Promise
Revolutionary Cancer Treatment Shows Promise
FDA Expands Approval of Vonvendi for von Willebrand Disease, Including Pediatric Use
Child Depression Fluctuations may trigger Parent Depression not vice versa: JAMA
Indoor Air Quality and Diet Found to Regulate Inflammation in Childhood: Study Finds
How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out
Follow Us:
November 05, 2025

Get In Touch

Bimekizumab Effectively Clears Skin Lesions In Severe Palmoplantar Pustular Psoriasis: JAMA Medicine

Bimekizumab Effectively Clears Skin Lesions In Severe Palmoplantar Pustular Psoriasis: JAMA

  • 17 July 2025
  • 3 months ago

Tralokinumab Monotherapy Effective In Moderate-To-Severe Atopic Dermatitis: Study Dermatology

Tralokinumab Monotherapy Effective In Moderate-To-Severe Atopic Dermatitis: Study

  • 17 July 2025
  • 3 months ago

Immunotherapy Drug Combination Helps Extend Survival In Patients With Metastatic Melanoma Dermatology

Immunotherapy Drug Combination Helps Extend Survival In Patients With Metastatic Melanoma

  • 17 July 2025
  • 3 months ago

FDA Approves Amtagavi For Treatment Of Advanced Melanoma Dermatology

FDA Approves Amtagavi For Treatment Of Advanced Melanoma

  • 17 July 2025
  • 3 months ago

Study Finds A Novel Prognostic Marker For Epidermal Necrolysis Dermatology

Study Finds A Novel Prognostic Marker For Epidermal Necrolysis

  • 17 July 2025
  • 3 months ago

Oral Tofacitinib, Novel Alternative Treatment For Resistant Alopecia Areata Among Children Pediatrics and Neonatology

Oral Tofacitinib, Novel Alternative Treatment For Resistant Alopecia Areata Among Children

  • 17 July 2025
  • 3 months ago

Cendakimab Shows Efficacy And Safety In Treating Moderate To Severe Atopic Dermatitis: Results From Clinical Trial Dermatology

Cendakimab Shows Efficacy And Safety In Treating Moderate To Severe Atopic Dermatitis: Results From Clinical Trial

  • 17 July 2025
  • 3 months ago

Jubilant Radiopharma Business Receives ANDA Approval For Technetium Sulfur Colloid Injection Obstetrics and Gynaecology

Jubilant Radiopharma Business Receives ANDA Approval For Technetium Sulfur Colloid Injection

  • 17 July 2025
  • 3 months ago

Rare Case Of Chinese Restaurant Syndrome With Dermatological Symptoms: A Report Diet

Rare Case Of Chinese Restaurant Syndrome With Dermatological Symptoms: A Report

  • 17 July 2025
  • 3 months ago

Use Of Topical Immunosuppressant Ointments May Not Increase Skin Cancer Risk: JAMA Dermatology

Use Of Topical Immunosuppressant Ointments May Not Increase Skin Cancer Risk: JAMA

  • 17 July 2025
  • 3 months ago

Recent News

HC pulls up NMC for not filing reply in FMG Intern...

  • 04 November, 2025

Eli Lilly plans to build new USD 3 billion facilit...

  • 04 November, 2025

Rajkot Maternity Hospital CCTV Leak: How a simple...

  • 04 November, 2025

Gland Pharma profit rises 12 percent to Rs 184 cro...

  • 04 November, 2025

AIIMS Delhi doctors told to use Hindi in prescript...

  • 04 November, 2025

Daily Newsletter

Get all the top stories from Blogs to keep track.